Your browser doesn't support javascript.
loading
Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis.
Gossec, Laure; Orbai, Ana-Maria; Coates, Laura C; Gladman, Dafna D; Ogdie, Alexis; Pelligra, Christopher G; Ciaravino, Valérie; Ink, Barbara; Taieb, Vanessa; Lambert, Jérémy; de Wit, Maarten.
Afiliación
  • Gossec L; INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Université, Paris, France laure.gossec@aphp.fr.
  • Orbai AM; Rheumatology Department, AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
  • Coates LC; Division of Rheumatology, John Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Gladman DD; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
  • Ogdie A; Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Pelligra CG; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Ciaravino V; Evidera, Medellín, Colombia.
  • Ink B; UCB Pharma, Colombes, France.
  • Taieb V; UCB Pharma, Slough, UK.
  • Lambert J; UCB Pharma, Colombes, France.
  • de Wit M; UCB Pharma, Colombes, France.
RMD Open ; 10(1)2024 Jan 31.
Article en En | MEDLINE | ID: mdl-38296802
ABSTRACT

OBJECTIVES:

To investigate psychometric performance of the 12-item Psoriatic Arthritis Impact of Disease (PsAID-12) total and individual item scores in patients with psoriatic arthritis (PsA) and to estimate score change thresholds and scores corresponding to different levels of symptom/impact severity.

METHODS:

Data up to week 16 from 1252 patients with active PsA enrolled in two randomised controlled trials of bimekizumab (BE OPTIMAL (NCT03895203) and BE COMPLETE (NCT03896581)) were used to assess construct validity (correlations with other patient-reported outcomes), known-groups validity (based on Minimal Disease Activity index, Disease Activity Index for Psoriatic Arthritis and Psoriatic Arthritis Disease Activity Score), reliability (Cronbach's alpha and intraclass correlation coefficients (ICCs)) and responsiveness (sensitivity to change). Clinically meaningful within-patient improvement thresholds were estimated by anchor-based and distribution-based analyses, and symptom/impact severity thresholds were estimated by receiver operating characteristic curve analyses.

RESULTS:

The mean (SD) PsAID-12 total score at baseline was 4.19 (1.94). PsAID-12 scores demonstrated good convergent validity and good known-groups validity. Internal consistency reliability (Cronbach's alpha 0.95) and test-retest reliability (ICC ≥ 0.70) were also good. Responsiveness was acceptable (correlations ≥0.30 for most scores). Improvement thresholds were estimated at 1.5-2 points for the PsAID-12 total score and 2 or 3 points for item scores. Thresholds for different levels of symptom/impact severity could be derived for most PsAID-12 items.

CONCLUSIONS:

The PsAID-12 demonstrated robust psychometric properties in a large sample of patients with active PsA, supporting its use as a fit-for-purpose patient-reported outcome in this population. Furthermore, thresholds for score interpretation were derived.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Artritis Psoriásica Tipo de estudio: Clinical_trials / Diagnostic_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: RMD Open Año: 2024 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Artritis Psoriásica Tipo de estudio: Clinical_trials / Diagnostic_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: RMD Open Año: 2024 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido